Matches in Wikidata for { <http://www.wikidata.org/entity/Q66082275> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q66082275 description "clinical trial" @default.
- Q66082275 description "ensayu clínicu" @default.
- Q66082275 description "klinisch onderzoek" @default.
- Q66082275 description "клінічне випробування" @default.
- Q66082275 name "Safety, Tolerability, PK, and Pharmacodynamics(PD) of IONIS APOCIII-LRx in Healthy Volunteers With Elevated Triglycerides" @default.
- Q66082275 name "Safety, Tolerability, PK, and Pharmacodynamics(PD) of IONIS APOCIII-LRx in Healthy Volunteers With Elevated Triglycerides" @default.
- Q66082275 type Item @default.
- Q66082275 label "Safety, Tolerability, PK, and Pharmacodynamics(PD) of IONIS APOCIII-LRx in Healthy Volunteers With Elevated Triglycerides" @default.
- Q66082275 label "Safety, Tolerability, PK, and Pharmacodynamics(PD) of IONIS APOCIII-LRx in Healthy Volunteers With Elevated Triglycerides" @default.
- Q66082275 prefLabel "Safety, Tolerability, PK, and Pharmacodynamics(PD) of IONIS APOCIII-LRx in Healthy Volunteers With Elevated Triglycerides" @default.
- Q66082275 prefLabel "Safety, Tolerability, PK, and Pharmacodynamics(PD) of IONIS APOCIII-LRx in Healthy Volunteers With Elevated Triglycerides" @default.
- Q66082275 P1050 Q66082275-EBAEE7E6-576F-491D-A722-7E39E9968CCA @default.
- Q66082275 P1132 Q66082275-A8224F3B-947E-4B0A-8DB4-CFBF96397B48 @default.
- Q66082275 P1476 Q66082275-B520FAD4-C71F-4A34-BAEA-5999FEF7F5B6 @default.
- Q66082275 P17 Q66082275-A15F6C98-C769-4463-8C2F-D52A956781B9 @default.
- Q66082275 P2899 Q66082275-6DBE9D71-A390-41BD-ADB9-34653076FBF3 @default.
- Q66082275 P3098 Q66082275-67D3257B-0423-425E-B65A-432FDD4FF140 @default.
- Q66082275 P31 Q66082275-C675859A-B01E-4AD9-B715-4112B2C7FEFD @default.
- Q66082275 P4135 Q66082275-10660A82-D230-4E68-B386-B820FEC1104D @default.
- Q66082275 P580 Q66082275-BF1B02BC-B8F4-4760-9BD6-E89B1B0080FB @default.
- Q66082275 P582 Q66082275-418B729E-B2E0-4091-BE7D-6FEABBD49AFB @default.
- Q66082275 P6099 Q66082275-708469BE-1ADD-489D-8014-DE59942FDCC3 @default.
- Q66082275 P8363 Q66082275-B8C5061B-3D84-4A98-AB31-48B16E31159B @default.
- Q66082275 P1050 Q1467339 @default.
- Q66082275 P1132 "+56" @default.
- Q66082275 P1476 "Placebo-Controlled, Dose-Escalation Study to Assess Safety, Tolerability, PK and PD of a GalNAc3 Conjugated Antisense Oligonucleotide Targeting ApoC-III, Administered Subcutaneously to Healthy Volunteers With Elevated Triglycerides" @default.
- Q66082275 P17 Q16 @default.
- Q66082275 P2899 "+18" @default.
- Q66082275 P3098 "NCT02900027" @default.
- Q66082275 P31 Q30612 @default.
- Q66082275 P4135 "+65" @default.
- Q66082275 P580 "2016-09-01T00:00:00Z" @default.
- Q66082275 P582 "2018-04-30T00:00:00Z" @default.
- Q66082275 P6099 Q5452194 @default.
- Q66082275 P8363 Q78089383 @default.